CRVO
CervoMed Inc.
+0.10 (+3.96%)2.54USD31.2K成交股數38.4M市值0.0本益比(近四季)115.8股價營收比-100.0%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 0.00-100% | 9K-100% | 323K-90% | 1.8M-25% | 1.9M-23% | 1.9M+27% | 3.3M+91% | 2.3M | 2.5M | 1.5M | 1.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.3M | 5.1M | 5.8M | 6.0M | 5.1M | 4.8M | 5.1M | 3.8M | 2.8M | 2.9M | 1.8M | 2.0M |
| 銷售管理費用 | 2.4M | 3.0M | 2.5M | 2.3M | 3.3M | 2.4M | 2.2M | 2.5M | 2.1M | 2.1M | 2.4M | 993K |
| 營業利益 | −6.7M+1% | −8.1M+53% | −8.3M+54% | −8.0M+169% | −6.6M+155% | −5.3M+114% | −5.4M+102% | −3.0M+143% | −2.6M | −2.5M | −2.7M | −1.2M |
| 營業利益率 | – | – | -95,479.2% | -2,493.8% | -376.4% | -276.6% | -278.2% | -91.1% | -110.6% | -99.6% | -175.2% | -71.6% |
| 稅後淨利 | −6.6M+5% | −8.0M+63% | −8.1M+70% | −7.7M+233% | −6.3M+149% | −4.9M+107% | −4.8M-321% | −2.3M+63% | −2.5M | −2.4M | 2.2M | −1.4M |
| 淨利率 | – | – | -92,722.0% | -2,395.3% | -356.1% | -255.2% | -245.1% | -70.4% | -107.1% | -94.8% | 140.9% | -82.9% |
| 稀釋 EPS | – | – | – | – | – | – | -0.55-21% | – | – | – | -0.70 | – |
| 稀釋股數 | – | – | – | – | – | – | 8.7M | – | – | – | 3.8M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22.5M | 7.9M | 8.2M | 9.4M | 8.3M | 10.5M | 7.7M | 10.0M | 6.4M | 7.8M | 10.4M | 15.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 26.0M | 15.1M | 22.9M | 30.6M | 38.1M | 38.6M | 48.9M | 53.2M | 8.0M | 10.0M | 12.0M | 3.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.0M | 4.5M | 4.7M | 4.6M | 4.6M | 3.9M | 3.2M | 3.2M | 2.7M | 2.6M | 2.5M | 14.2M |
| 股東權益 | 23.0M | 10.6M | 18.2M | 26.0M | 33.4M | 34.6M | 45.6M | 50.0M | 5.3M | 7.4M | 9.6M | −35.1M |
| 負債比 | 11.7% | 29.8% | 20.4% | 15.0% | 12.2% | 10.2% | 6.6% | 6.0% | 33.3% | 26.0% | 20.5% | 421.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.0M+106% | – | – | – | −3.9M | – | – | −1.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.0M | -58.9% | −27.0M | -673.2% | – | – |
| FY2024 | 9.7M | +36.3% | −16.3M | -167.3% | – | – |
| FY2023 | 7.1M | – | −2.2M | -30.4% | – | – |
| FY2022 | 0.00 | – | −5.8M | –% | 2038891.00 | – |
| FY2021 | – | – | −24.1M | –% | 1946859.00 | – |
| FY2020 | – | – | −14.2M | –% | 53831973.00 | – |
| FY2019 | – | – | −11.8M | –% | 6706509.00 | – |
| FY2018 | – | – | −18.4M | –% | 3242301.00 | – |